WASHINGTON, D.C. — The Food and Drug Administration (FDA) announced that Abbott has initiated a voluntary recall for a ...

Abbott, a leader in diabetes tech with one of the biggest lines of continuous glucose monitors, announced this week that it's ...

Abbott has launched the new Libre app in the U.S., making it easier than ever for users of both the FreeStyle Libre 2 and FreeStyle Libre 3 systems to track glucose readings and insights.

Abbott's wearable FreeStyle Libre 3 device – which is billed as the smallest and thinnest real-time CGM system available – sends glucose readings every minute directly to the user's smartphone ...